Ian Marschner

Professor

Professor, Department of Mathematics and Statistics

https://orcid.org/0000-0002-6225-1572

Emailian.marschner@mq.edu.au

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Ian Marschner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

5 Finished

Statistical methodology for the pharmaceutical industry - Stage 2
Marschner, I.
21/12/18 → 20/12/19
Project: Other
Statistical analysis of clinical trials: theory, methods and software
Marschner, I.
1/08/16 → 31/01/17
Project: Research
Advancing the evidence base for care and policy in priority health areas
Marschner, I. & MQRES, M.
1/01/13 → 31/12/17
Project: Research
New statistical methodology for clinical and epidemiological research
Marschner, I.
1/08/12 → 31/01/13
Project: Research
Binary regression with additive predictors: new statistical theory with healthcare applications
Marschner, I., Gebski, V., Newton, J. & MQRES, M.
1/01/11 → 30/09/16
Project: Research

5488 Citations
27 h-Index
89 Article
4 Conference proceeding contribution
4 Review article
2 Abstract
6 More

Efficacy of immune checkpoint inhibitors in older adults with advanced stage cancers: a meta-analysis
Kasherman, L., Siu, D. H. W., Lee, K. W. C., Lord, S., Marschner, I., Lewis, C. R., Friedlander, M. & Lee, C. K., Apr 2020, In : Journal of Geriatric Oncology. 11, 3, p. 508-514 7 p.
Research output: Contribution to journal › Article
6 Citations (Scopus)
Sensitivity analyses assessing the impact of early stopping on systematic reviews: recommendations for interpreting guidelines
Marschner, I. C., Askie, L. M. & Schou, I. M., Mar 2020, In : Research Synthesis Methods. 11, 2, p. 287-300 14 p.
Research output: Contribution to journal › Article
The AGITG GAP Study: a Phase II study of perioperative gemcitabine and nab-paclitaxel for resectable pancreas cancer
Barbour, A. P., Samra, J. S., Haghighi, K. S., Donoghoe, M. W., Burge, M., Harris, M. T., Chua, Y. J., Mitchell, J., O’Rourke, N., Chan, H., Gebski, V. J., Gananadha, S., Croagh, D. G., Kench, J. G., Goldstein, D. & Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigators, 1 Jul 2020, In : Annals of Surgical Oncology. 27, 7, p. 2506-2515 10 p.
Research output: Contribution to journal › Article
1 Citation (Scopus)
Changes in plasma lipids predict pravastatin efficacy in secondary prevention
LIPID Study Investigators, 11 Jul 2019, In : JCI Insight. 4, 13, p. 1-13 13 p., e128438.
Research output: Contribution to journal › Article

Open Access
Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer
Woodford, R., Loh, Y., Lee, J., Cooper, W., Marschner, I., Lewis, C. R., Millward, M., Lord, S., Gralla, R. J., Yang, J. C-H., Mok, T. & Lee, C. K., Jul 2019, In : Future Oncology. 15, 20, p. 2371-2383 13 p.
Research output: Contribution to journal › Review article